• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

台湾地区癌症确诊后工作年龄患者的经济困难与生存情况的关联

Association of financial hardship and survival in working-age patients following cancer diagnosis in Taiwan.

作者信息

Ciou Yi-Yun Claire, Chien Li-Nien

机构信息

Institute of Health and Welfare Policy, College of Medicine, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan.

出版信息

Oncologist. 2025 Jun 4;30(6). doi: 10.1093/oncolo/oyaf140.

DOI:10.1093/oncolo/oyaf140
PMID:40525912
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12200238/
Abstract

BACKGROUND

Extreme income or asset loss as severe form of financial hardship (FH) has been linked to worse survival outcomes in cancer patients. This study aimed to assess the incidence, risk factors, and impact of severe financial hardship (SFH) on survival among working-age cancer patients in Taiwan's universal healthcare system, using an objective measure for SFH.

METHODS

This study analyzed linked national longitudinal data for patients aged 20-63 years diagnosed with cancer between 2007 and 2018. Severe financial hardship was defined as household net income falling below the poverty threshold post-diagnosis. Propensity score matching (1:4) was used to balance baseline characteristics between SFH and non-SFH groups. Cox proportional hazard models were used to estimate the hazard ratio (HR) of outcomes.

RESULTS

Among 400 229 working-age cancer patients, the incidence of SFH was 4.7 per 1000 person-years (95% confidence interval [CI], 4.6-4.9) over a mean follow-up of 5.7 ± 4.3 years. Severe financial hardship was associated with younger age, male sex, advanced stage, and intensive treatments. Patients with SFH within 1 year of diagnosis had significantly lower survival, with an adjusted HR of 1.64 (95% CI, 1.56-1.72) for all-cause mortality compared to those without SFH. Notably, early stage patients with SFH faced a higher relative mortality risk than advanced-stage patients.

CONCLUSIONS

Severe financial hardship substantially increases mortality among cancer patients in Taiwan, highlighting gaps in financial protection. Addressing SFH through implementing targeted policies and enhancing support mechanisms is essential to improve survival outcomes and reduce disparities in cancer care.

摘要

背景

极端收入或资产损失作为严重形式的经济困难(FH),已与癌症患者较差的生存结果相关联。本研究旨在使用一种针对严重经济困难(SFH)的客观衡量方法,评估台湾全民医保体系中劳动年龄癌症患者的严重经济困难的发生率、风险因素及其对生存的影响。

方法

本研究分析了2007年至2018年间确诊为癌症的20至63岁患者的全国纵向关联数据。严重经济困难定义为诊断后家庭净收入低于贫困线。采用倾向得分匹配(1:4)来平衡SFH组和非SFH组之间的基线特征。使用Cox比例风险模型估计结局的风险比(HR)。

结果

在400229名劳动年龄癌症患者中,平均随访5.7±4.3年期间,SFH的发生率为每1000人年4.7例(95%置信区间[CI],4.6 - 4.9)。严重经济困难与年龄较小、男性、晚期和强化治疗相关。诊断后1年内出现SFH的患者生存率显著较低,与无SFH的患者相比,全因死亡率调整后的HR为1.64(95%CI,1.56 - 1.72)。值得注意的是,早期患有SFH的患者面临的相对死亡风险高于晚期患者。

结论

严重经济困难显著增加了台湾癌症患者的死亡率,凸显了经济保护方面的差距。通过实施针对性政策和加强支持机制来解决SFH对于改善生存结局和减少癌症护理方面的差距至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef6/12200238/9af003d72b51/oyaf140_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef6/12200238/594f9bfdef57/oyaf140_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef6/12200238/824a6ec0e0eb/oyaf140_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef6/12200238/51fc8acf1c22/oyaf140_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef6/12200238/9af003d72b51/oyaf140_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef6/12200238/594f9bfdef57/oyaf140_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef6/12200238/824a6ec0e0eb/oyaf140_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef6/12200238/51fc8acf1c22/oyaf140_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef6/12200238/9af003d72b51/oyaf140_fig4.jpg

相似文献

1
Association of financial hardship and survival in working-age patients following cancer diagnosis in Taiwan.台湾地区癌症确诊后工作年龄患者的经济困难与生存情况的关联
Oncologist. 2025 Jun 4;30(6). doi: 10.1093/oncolo/oyaf140.
2
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
3
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
4
": A Mixed Methods Investigation of Employment, Stigma, and Financial Hardship Among LGBTQ+ Cancer Caregivers.《LGBTQ+癌症护理者的就业、耻辱感和经济困难的混合方法调查》
Cancer Control. 2025 Jan-Dec;32:10732748251351105. doi: 10.1177/10732748251351105. Epub 2025 Jun 14.
5
Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.未治疗的霍奇金淋巴瘤患者化疗和放疗在第二原发性恶性肿瘤、总生存期和无进展生存期方面的优化:个体参与者数据分析
Cochrane Database Syst Rev. 2017 Sep 13;9(9):CD008814. doi: 10.1002/14651858.CD008814.pub2.
6
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
7
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.
8
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
10
Mortality Outcomes for Survivors of Cancer With Food Insecurity in the US.美国粮食不安全的癌症幸存者的死亡率结果
JAMA Health Forum. 2025 Jun 7;6(6):e251381. doi: 10.1001/jamahealthforum.2025.1381.

本文引用的文献

1
Social Characteristics and Adherence to Adjuvant Endocrine Therapy in Premenopausal Women With Breast Cancer.社会特征与乳腺癌绝经前妇女辅助内分泌治疗的依从性。
J Clin Oncol. 2024 Oct;42(28):3300-3307. doi: 10.1200/JCO.23.02643. Epub 2024 Jun 25.
2
Cancer diagnosis and treatment in working-age adults: Implications for employment, health insurance coverage, and financial hardship in the United States.美国工作年龄段成年人的癌症诊断和治疗:对就业、医疗保险覆盖范围和经济困难的影响。
CA Cancer J Clin. 2024 Jul-Aug;74(4):341-358. doi: 10.3322/caac.21837. Epub 2024 Apr 23.
3
Association of Employment Disruptions and Financial Hardship Among Individuals Diagnosed with Cancer in the United States: Findings from a Nationally Representative Study.
美国被诊断患有癌症的个体中就业中断和经济困难的关联:一项全国代表性研究的结果。
Cancer Res Commun. 2023 Sep 12;3(9):1830-1839. doi: 10.1158/2767-9764.CRC-23-0157. eCollection 2023 Sep.
4
Cancer treatment-related financial toxicity in Japan: a scoping review.日本癌症治疗相关的经济毒性:一项范围综述
Front Psychol. 2023 Aug 1;14:1205016. doi: 10.3389/fpsyg.2023.1205016. eCollection 2023.
5
Financial toxicity among cancer patients, survivors and their families in the United Kingdom: a scoping review.英国癌症患者、幸存者及其家属的财务毒性:范围综述。
J Public Health (Oxf). 2023 Nov 29;45(4):e702-e713. doi: 10.1093/pubmed/fdad143.
6
Family and Caregiver Financial Toxicity Associated With Cancer-A Global, Inequitable, and Urgent Consideration.与癌症相关的家庭和照护者经济毒性——一项全球、不公平且亟待关注的问题
JAMA Netw Open. 2023 Jun 1;6(6):e2319317. doi: 10.1001/jamanetworkopen.2023.19317.
7
Compliance to adjuvant endocrine therapy and survival in breast cancer patients.辅助内分泌治疗的依从性与乳腺癌患者的生存。
Cancer Treat Res Commun. 2023;35:100704. doi: 10.1016/j.ctarc.2023.100704. Epub 2023 Apr 4.
8
Discussion of costs and financial burden in clinical practice: A survey of medical oncologists in Australia.临床实践中的成本和经济负担探讨:澳大利亚肿瘤医生的调查。
PLoS One. 2022 Oct 21;17(10):e0273620. doi: 10.1371/journal.pone.0273620. eCollection 2022.
9
Assessing Patient-Reported Financial Hardship in Patients With Cancer in Routine Clinical Care.评估常规临床护理中癌症患者的患者报告经济困难。
JCO Oncol Pract. 2022 Nov;18(11):e1839-e1853. doi: 10.1200/OP.22.00276. Epub 2022 Sep 27.
10
Physicians' Perspectives on Ethical Issues Regarding Expensive Anti-Cancer Treatments: A Qualitative Study.医生对昂贵抗癌治疗相关伦理问题的看法:一项定性研究。
AJOB Empir Bioeth. 2022 Oct-Dec;13(4):275-286. doi: 10.1080/23294515.2022.2110963. Epub 2022 Aug 26.